bioRxiv · 10.64898/2026.06.08.730855
Nanopore Direct RNA Sequencing Enables Reproducible, Site-Resolved Pseudouridine Quantification in Human Ribosomal RNA
Abstract
Pseudouridine is the most abundant post-transcriptional modification in human ribosomal RNA, with over 110 annotated sites and variable stoichiometry across biological contexts. Existing quantification methods are low-throughput or constrained to predefined panels. We benchmarked nanopore direct RNA sequencing using the Dorado v5.1 model against mass spectrometry-validated sites in human liver tissue, induced pluripotent stem cells, and HeLa cells. Nanopore sequencing detected 95 of 117 validated sites and accurately quantified stoichiometry at 85% of sites with high reproducibility. Low GC-content environments were the primary source of failure. These results establish nanopore sequencing as a scalable tool for epitranscriptomic pseudouridine profiling.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
S de Preval, B., Faucher-Giguere, L., Duval, M., Marchand, V., Lakshmi Narasimha, P., Thakor, N., Motorin, Y., Abou Elela, S., Scott, M. S.. 2026-06-08. Nanopore Direct RNA Sequencing Enables Reproducible, Site-Resolved Pseudouridine Quantification in Human Ribosomal RNA. https://doi.org/10.64898/2026.06.08.730855
Cite the original work for its findings. Save a collection to share your selection of sources.